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Thrombosis / Thromboembolism of the descending aorta (A T E) in dogs, 
diagnosis, pathophysiologic and therapeutic considerations. 
Tony Glaus, Prof. Dr. med. Vet., Dipl. ACVIM and ECVIM-CA, Head Division of Cardiology, 
Vetsuisse Faculty University of Zurich, CH-8057 Zurich 
 
Definitions 
Thrombosis is the local formation of a thrombus inside a vessel leading to vascular occlusion, 
embolism is the vascular occlusion by various formations like a thrombus, tissue particle, 
parasite, foreign body, tumor cells or air that have been formed distant to the actual occlusion 
and that are carried in the vessel to the site of occlusion, and thromboembolism is thus the 
vascular occlusion specifically by a thrombus that was not produced at the site of occlusion 
but carried there. Once a thrombus is present in the circulation it may grow. In this text, the 
abbreviation ATE will be used to describe both aortic thrombosis and / or thromboembolism.  
 
Pathogenesis 
For ATE to occur an important disturbance in the delicate balance between pro- and 
antithrombotic body systems has to be present, i.e. there may be excessive abnormal focal 
vascular triggers of coagulation, or a systemic hypercoagulable state, or a systemic 
hypofibrinolytic state, or a combination of these. The following notes focus on ATE in dogs.  
As opposed to cats, ATE is not a very common problem in dogs. Furthermore, causes of ATE 
markedly differ in cats and dogs. In cats, around 90% of cases are due to thrombus formation 
in the left atrium (or ventricle) secondary to stagnant blood flow, mostly due to a severely 
dilated left atrium secondary to myocardial disease. Around 10% are due to cancer, most 
commonly carcinomata in the chest. In dogs, ATE is not encountered with atrial dilation, even 
if severe. As a matter of fact, in many cases no eliciting cause is identified. In some dogs ATE 
has been reported associated with local vascular pathology, specifically atherosclerosis in the 
descending aorta, or (adrenal) cancer breaking into the aorta. Furthermore, it has been 
associated (published and unpublished) with systemic diseases, including Leishmaniosis, 
nephrotic syndrome (some due to leishmaniasis), protein-losing enteropathy, hypothyroidism, 
hyperadrenocorticism, endocarditis, ectopic heart worms, cancer, unspecified nephropathy 
and unspecified cardiac disease.  
 
C linical signs, differential diagnosis and further diagnostics 
Whereas in some dogs, clinical signs may be peracute with pain, paraplegia, cold extremities, 
paresthesia and no palpable pulse, like in cats, more commonly the onset of gait abnormalities 
may be insidious and worsen progressively. A femoral pulse may still be palpable delaying 
the suspicion of ischemic myopathy as cause of the gait abnormality. Characteristic for 
narrowing of the aorta and decreased oxygen delivery to the rear legs is exercise induced 
intermittent claudication. The differential diagnosis for this includes right-to-left PDA, 
myasthenia gravis, neuropathies and myopathies.  When a pulse is still palpable, it takes a 
high index of suspicion to consider ATE. In some cases, ATE is found incidentally during 
abdominal ultrasound. The minimal data base to search for a potential underlying cause 
includes routine hematology, biochemical profile, urinalysis, urine-proteine-creatinine-ratio, 
thoracic radiographs and abdominal ultrasound. The latter also is necessary to prove the 
diagnosis. Further tests may include infectious disease titers (Leishmania), and abdominal CT.  
 
T reatment 
The treatment aims at 1. symptomatically fight the pain, 2. eliminate the thrombus, 3. 
eliminate the underlying cause.  
To eliminate the thrombus medically, fibrinolytic and antithrombotic therapy are possible. 
Complications with both include  
- breaking off of part of the thrombus, which may cause complete arterial obstruction 
lower in the arteries, which may lead to paraplegia of a previously ambulatory patient.  
- Spontaneous bleeding. 
In a patient with acute paraplegia and pulselessness of very recent onset, we would consider 
fibrinolytic treatment using tissue plasminogen activator. In this scenario, an additional risk is 
severe hyperkalemia secondary to acute reperfusion. In a still ambulatory patient, our 
approach today is the application of the low-molecular-weight heparin enoxaparine (0.8 
mg/kgq6h, ClexaneR) combined with the antiplatelet drug clopidogrel (2-3 mg/kg q24h, 
PlavixR). To assure that the enoxaparine blood level is in the target range, anti-factorXa-
activity is assessed using the human assay. When the thrombus is completely dissolved based 
on ultrasonographic examination of the descending aorta, the enoxaparine dose is slowly 
decreased, but never completely stopped. Enoxaparine is expensive. 
 
Prognosis 
Basically poor, but better than in cats. Depends on underlying cause, onset acute versus 
chronic, still ambulatory versus paraplegic, and severity of secondary complications like 
neuropathies, muscle necrosis / fibrosis. Complete recanalisation is possible, however, 
breaking off of parts of the thrombus may occlude distal arteries with acute paraplegia in a 
previously walking dog. Relapses are possible. 
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